BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20643896)

  • 1. The virucidal EB peptide protects host cells from herpes simplex virus type 1 infection in the presence of serum albumin and aggregates proteins in a detergent-like manner.
    Bultmann H; Girdaukas G; Kwon GS; Brandt CR
    Antimicrob Agents Chemother; 2010 Oct; 54(10):4275-89. PubMed ID: 20643896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified FGF4 signal peptide inhibits entry of herpes simplex virus type 1.
    Bultmann H; Busse JS; Brandt CR
    J Virol; 2001 Mar; 75(6):2634-45. PubMed ID: 11222686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of herpes simplex virus type 1 infection by cationic beta-peptides.
    Akkarawongsa R; Potocky TB; English EP; Gellman SH; Brandt CR
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2120-9. PubMed ID: 18391029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of a C-terminal cysteine improves the anti-herpes simplex virus activity of a peptide containing the human immunodeficiency virus type 1 TAT protein transduction domain.
    Bultmann H; Teuton J; Brandt CR
    Antimicrob Agents Chemother; 2007 May; 51(5):1596-607. PubMed ID: 17261627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus.
    Jenssen H; Andersen JH; Mantzilas D; Gutteberg TJ
    Antiviral Res; 2004 Nov; 64(2):119-26. PubMed ID: 15498607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.
    Akkarawongsa R; Pocaro NE; Case G; Kolb AW; Brandt CR
    Antimicrob Agents Chemother; 2009 Mar; 53(3):987-96. PubMed ID: 19104014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginkgolic Acid Inhibits Herpes Simplex Virus Type 1 Skin Infection and Prevents Zosteriform Spread in Mice.
    Bhutta MS; Shechter O; Gallo ES; Martin SD; Jones E; Doncel GF; Borenstein R
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33435520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of herpes simplex type 1 and type 2 infections by Oximacro(®), a cranberry extract with a high content of A-type proanthocyanidins (PACs-A).
    Terlizzi ME; Occhipinti A; Luganini A; Maffei ME; Gribaudo G
    Antiviral Res; 2016 Aug; 132():154-64. PubMed ID: 27321663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro.
    Schuhmacher A; Reichling J; Schnitzler P
    Phytomedicine; 2003; 10(6-7):504-10. PubMed ID: 13678235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type I interferon production during herpes simplex virus infection is controlled by cell-type-specific viral recognition through Toll-like receptor 9, the mitochondrial antiviral signaling protein pathway, and novel recognition systems.
    Rasmussen SB; Sørensen LN; Malmgaard L; Ank N; Baines JD; Chen ZJ; Paludan SR
    J Virol; 2007 Dec; 81(24):13315-24. PubMed ID: 17913820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cationic TAT peptide inhibits Herpes simplex virus type 1 infection of human corneal epithelial cells.
    Larsen IV; Brandt CR
    J Ocul Pharmacol Ther; 2010 Dec; 26(6):541-7. PubMed ID: 21029018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic Inactivation of Herpes Simplex Viruses.
    Monjo AL; Pringle ES; Thornbury M; Duguay BA; Monro SMA; Hetu M; Knight D; Cameron CG; McFarland SA; McCormick C
    Viruses; 2018 Sep; 10(10):. PubMed ID: 30274257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro inhibition of the cytopathic action of herpes simplex virus, type 1, with a natural cytokine complex].
    Koval'chuk LV; Lavrov VF; Gankovskaia LV; Ebralidze LK; Barkevich OA
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (1):57-60. PubMed ID: 15773402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-molecular weight mannogalactofucans prevent herpes simplex virus type 1 infection via activation of Toll-like receptor 2.
    Kim WJ; Choi JW; Jang WJ; Kang YS; Lee CW; Synytsya A; Park YI
    Int J Biol Macromol; 2017 Oct; 103():286-293. PubMed ID: 28522392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of two synthetic amphiphilic peptides and magainin-2 against herpes simplex virus types 1 and 2.
    Aboudy Y; Mendelson E; Shalit I; Bessalle R; Fridkin M
    Int J Pept Protein Res; 1994 Jun; 43(6):573-82. PubMed ID: 7928088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel antiviral activity of mung bean sprouts against respiratory syncytial virus and herpes simplex virus -1: an in vitro study on virally infected Vero and MRC-5 cell lines.
    Hafidh RR; Abdulamir AS; Abu Bakar F; Sekawi Z; Jahansheri F; Jalilian FA
    BMC Complement Altern Med; 2015 Jun; 15():179. PubMed ID: 26062546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proanthocyanidin-enriched extract from Myrothamnus flabellifolia Welw. exerts antiviral activity against herpes simplex virus type 1 by inhibition of viral adsorption and penetration.
    Gescher K; Kühn J; Lorentzen E; Hafezi W; Derksen A; Deters A; Hensel A
    J Ethnopharmacol; 2011 Mar; 134(2):468-74. PubMed ID: 21211557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Euphorbia thymifolia suppresses herpes simplex virus-2 infection by directly inactivating virus infectivity.
    Yang CM; Cheng HY; Lin TC; Chiang LC; Lin CC
    Clin Exp Pharmacol Physiol; 2005; 32(5-6):346-9. PubMed ID: 15854140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A boost to the antiviral activity: Cholesterol tagged peptides derived from glycoprotein B of Herpes Simplex virus type I.
    Lombardi L; Falanga A; Del Genio V; Palomba L; Galdiero M; Franci G; Galdiero S
    Int J Biol Macromol; 2020 Nov; 162():882-893. PubMed ID: 32569683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective deploying of a novel DHODH inhibitor against herpes simplex type 1 and type 2 replication.
    Luganini A; Sibille G; Mognetti B; Sainas S; Pippione AC; Giorgis M; Boschi D; Lolli ML; Gribaudo G
    Antiviral Res; 2021 May; 189():105057. PubMed ID: 33716051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.